DUALITY ADVISERS, LP - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 273 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 3.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
DUALITY ADVISERS, LP ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$999,800
-8.8%
32,588
+19.2%
0.12%
-12.3%
Q2 2023$1,095,794
+100.4%
27,347
+93.1%
0.14%
+122.6%
Q4 2022$546,872
-2.3%
14,164
+41.6%
0.06%
+44.2%
Q3 2021$560,000
-60.4%
10,000
-57.1%
0.04%
-65.9%
Q2 2021$1,415,000
-6.4%
23,326
-7.6%
0.13%
+11.5%
Q4 2020$1,511,00025,2510.11%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 2,799,916$121,768,0008.62%
Tamarack Advisers, LP 625,000$27,044,0008.22%
NEXTHERA CAPITAL LP 149,086$6,484,0005.40%
Spyglass Capital Management LLC 379,609$16,509,0005.22%
Gagnon Advisors, LLC 107,412$4,671,0002.67%
GAGNON SECURITIES LLC 278,613$12,117,0002.61%
Asymmetry Capital Management, L.P. 84,735$3,685,0002.00%
Rock Springs Capital Management LP 1,250,000$54,363,0001.97%
Lisanti Capital Growth, LLC 118,620$5,159,0001.68%
Elk Creek Partners, LLC 500,069$21,748,0001.62%
View complete list of PACIRA PHARMACEUTICALS INC shareholders